Varicose Vein Treatment Market By Product 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Varicose Vein Treatment Market
Varicose Vein Treatment Market: By Product (Radiofrequency Ablation Devices, Laser Ablation Devices and Surgical Products); By Treatment (Sclerotherapy, Endovenous Laser Ablation, Stripping, Ambulatory Phlebectomy, Radiofrequency Ablation) & Geography -Forecast (2017-2021)
Report Code : HCR 0712
Published: 26 April, 2017  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
Varicose Veins also referred to as varicosities are swollen, blue, twisted veins that appear on the skin. These are often seen near the legs. High pressure in the veins and when one or more veins fail to close, varicose veins appear. They affect almost anyone regardless of age. However, they are most frequently seen in female population, obese population and generally over 45 years of age. Various causes for the occurrence of varicose vein include obesity, hereditary elements and standing or sitting for a long period of time. Risk of occurrence of varicose vein is high during pregnancy period because of large volume flow of blood which causes the expansion of walls.

Various methods are being adopted for the treatment of varicose veins of which endovenous laser ablation (EVLA) is the majorly adopted technique as the success ratio and procedure adopted is often simple in comparison with others. EVLA uses high quality laser to heat up and close the veins under the guidance of duplex ultrasound. Radiofrequency Ablation Devices use electrical energy to generate heat affected veins and thus close them.

Varicose Vein Treatment Market

Laser ablation and Radiofrequency ablation are similar methods. In this laser ablation, laser generator, laser fiber, and console are used. The laser utilizes much focused light to generate heat. Another method used is surgical vein stripping, a surgical procedure,  where specialists tie off the concerned vein and totally expel them from the leg through little cuts in the skin.

Demand for endovenous ablation treatments such as varicose vein treatment devices is anticipated to expand at a rapid pace in the next few years due to factors such as short treatment time, improved blood circulation, minimal invasion, and complete closure of the treated area. Ultrasound sclerotherapy devices have also been witnessing moderate demand owing to benefits such as time and cost efficiency, of reduced risk collateral damage to surrounding tissues, painless procedure, increased penetration, no requirement of anesthesia, fewer post-operative complications, less scarring, and minimal need for incisions during the procedure.

Asia Pacific will have the fastest growth, owing to a rapid increase in aging population; rise in consumer awareness; ease of treatment as a result of government policies; modernization of healthcare infrastructure; and growing medical tourism industry. This can be observed in developing nations such as China, and India in this region. Among all the treatments, the ultrasound and sclerotherapy segment is widely used in the varicose vein treatment market due to the larger benefits, minimal incision, and reduced scaring. 

Competitive landscape for each of the functions performed and form of existence of varicose vein treatments are highlighted and key market players are profiled with attributes of business overview, financials, business strategies, product portfolio and recent developments pertaining to varicose vein treatments. Varicose veins Market shares of the key players for 2016 are also provided.

Sample Companies Profiled in this Report are:
  • Medtronic,
  • BTG PLC,
  • Vascular Solutions,
  • Syneron Medical,
  • Angiodynamics Inc,
  • 10+.
1. Varicose Vein Treatment Market overview
2. Executive summary
3. Varicose Vein Treatment Market landscape
   3.1. Market share analysis
   3.2. Comparative analysis
      3.2.1. Product Benchmarking
      3.2.2. End user profiling
      3.2.3. Patent Analysis
      3.2.4. Top 5 Financials Analysis
4. Varicose Vein Treatment Market forces
   4.1. Market drivers
   4.2. Market constraints
   4.3. Market challenges
   4.4. Porters five force model
      4.4.1. Bargaining power of suppliers
      4.4.2. Bargaining powers of customers
      4.4.3. Threat of new entrants
      4.4.4. Rivalry among existing players
      4.4.5. Threat of substitutes 
5. Varicose Vein Treatment Market Strategic analysis
   5.1. Value chain analysis
   5.2. Pricing analysis
   5.3. Opportunities analysis
   5.4. Product life cycle
   5.5. Suppliers and distributors
6. Varicose Vein Treatment Market – By Product
   6.1. Radiofrequency Ablation Devices
   6.2. Laser Ablation Devices
   6.3. Surgical Products 
7. Varicose Vein Treatment Market – By Treatment
   7.1. Sclerotherapy
   7.2. Endovenous Laser Ablation
   7.3. Stripping
   7.4. Ambulatory Phlebectomy
   7.5. Radiofrequency Ablation 
8. Varicose Vein Treatment Market – By Geography
   8.1. Americas
      8.1.1. US
      8.1.2. Canada
      8.1.3. Mexico
      8.1.4. Brazil
      8.1.5. Rest of Americas
   8.2. Europe
      8.2.1. UK
      8.2.2. Germany
      8.2.3. France
      8.2.4. Italy
      8.2.5. Rest of Europe
   8.3. APAC
      8.3.1. China
      8.3.2. Japan
      8.3.3. India
      8.3.4. Rest of APAC
   8.4. RoW
      8.4.1. Middle East
      8.4.2. Africa
9. Company profiles
   9.1. Angiodynamics, Inc.
   9.2. Biolitec AG
   9.3. BTG Plc.
   9.4. Energist Medical Solutions
   9.5. Eufoton S.R.L
   9.6. Lumenis Ltd.
   9.7. Medtronic, Inc.
   9.8. Quanta System S.p.A
   9.9. Syneron Medical Ltd.
   9.10. Vascular Solutions, Inc.
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix 
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Bibliography
   10.5. Compilation of Experts
   10.6. Disclaimer
List of Tables:

Table 1 Global Varicose Veins Market Revenue, By Geography, 2016-2021 ($Million)
Table 2 Americas: Varicose veins Market Revenue, By Treatment 2016-2021 ($ Million)
Table 3 Europe: Varicose veins Market Revenue, By Treatment 2016-2021 ($ Million)
Table 4 APAC Varicose Veins Market Revenue, By Treatment Type, 2016-2021 ($Million)
Table 5 RoW: Varicose veins Market Revenue, By Treatment 2016-2021 ($ Million)


List of Figures:

Figure 1 Varicose Vein Treatment Market Revenue, By Years, 2016-2021 ($Million)
Figure 2 Varicose Vein Treatment Market Revenue, By Treatment, 2016 (%)
Figure 3 Varicose Vein Treatment Market Revenue, By Region, 2016 
Figure 4 Varicose Vein Treatment Market Share Analysis, By Company 2015 (%)
Figure 5 Earnings Per Share (EPS – Varicose Vein Treatment Providers), By Company 
Figure 6 Varicose Vein Treatment Patents, 2012-2017 (*Jan)
Figure 7 Varicose Vein Treatment Patents, By Countries, 2012-2017 (%) 
Figure 8 Varicose Vein Treatment Market Life Cycle, 2016.2021
Figure 9 Varicose Vein Treatment Market Revenue Share, By Product, 2016 (%)
Figure 10 Radiofrequency Ablation Devices: Varicose Vein Treatment Market Revenue, 2016-2021 ($Million)
Figure 11 Laser Ablation Device: Varicose Vein Treatment Market Revenue, 2016-2021 ($Million)
Figure 12 Surgical Products: Varicose Vein Treatment Market Revenue, 2016-2021 ($Million)
Figure 13 Varicose Vein Treatment Market Revenue Share, By Treatment, 2016 (%)
Figure 14 Sclerotherapy: Varicose Vein Treatment Market Revenue, 2016-2021 ($Million)
Figure 15 Endovenous Laser Ablation: Varicose Vein Treatment Market Revenue,2016-2021 ($Million)
Figure 16 Stripping: Varicose Vein Treatment Market Revenue, 2016-2021 ($Million)
Figure 17 Radiofrequency Ablation: Varicose Vein Treatment Market Revenue, 2016-2021 ($Million)
Figure 18 Ambulatory Phlebectomy : Varicose Vein Treatment Market Revenue, 2016-2021 ($Million)
Figure 19 Americas: Varicose veins Market Revenue, By Product 2016-2021 ($ Million)
Figure 20 U.S Total Population above 65 years of age, 2012-2015 (%)
Figure 21 U.S Male-Female Population,2010-2015(%)
Figure 22 U.S: Varicose veins Market Revenue, 2015 ($)
Figure 23 U.S: Varicose veins Market Revenue, 2015 (%)
Figure 24 Canada: Total Population above 65 years of age, 2012-2015 (%)
Figure 25 Mexico: Total Population above 65 years of age, 2012-2015 (%)
Figure 26 Brazil: Total Population above 65 years of age, 2012-2015 (%)
Figure 27 Canada: Male-Female Population, 2010-2015 (%)
Figure 28 Mexico: Male-Female Population, 2010-2015 (%)
Figure 29 Brazil: Male-Female Population, 2010-2015 (%)
Figure 30 Canada: Varicose veins Market Revenue, 2016-2021 ($ Million)
Figure 31 Brazil: Varicose veins Market Revenue, 2016-2021 ($ Million)
Figure 32 Mexico: Varicose veins Market Revenue, 2016-2021 ($ Million)
Figure 33 Rest of Americas: Varicose veins Market Revenue, 2016-2021 ($ Million)
Figure 34 Europe: Varicose veins Market Revenue, By Product 2016-2021 ($ Million)
Figure 35 Germany: Total Population above 65 years of age, 2012-2015 (%) 
Figure 36 Italy: Total Population above 65 years of age, 2012-2015 (%)
Figure 37 France: Total Population above 65 years of age, 2012-2015 (%)
Figure 38 UK: Total Population above 65 years of age, 2012-2015 (%)
Figure 39 Germany: Male-Female Population, 2010-2015 (%)
Figure 40 Itlay: Male-Female Population, 2010-2015 (%)
Figure 41 France: Male-Female Population, 2010-2015 (%)
Figure 42 UK: Male-Female Population, 2010-2015 (%)
Figure 43 UK: Varicose veins Market Revenue, 2016-2021 ($ Million)
Figure 44 Germany: Varicose veins Market Revenue, 2016-2021 ($ Million)
Figure 45 France: Varicose veins Market Revenue, 2016-2021 ($ Million)
Figure 46 Itlay: Varicose veins Market Revenue, 2016-2021 ($ Million)
Figure 47 Rest of Europe: Varicose veins Market Revenue, 2016-2021 ($ Million)
Figure 48 APAC: Varicose veins Market Revenue, By Product 2016-2021 ($ Million)
Figure 49 China Female Demographics (In Thousands), By Age Group (2000-2030)
Figure 50 India Female Population (in Thousands), By Age Group (2000-2025)
Figure 51 Japan Female Population (in Thousands), By Age Group (2000-2025)
Figure 52 China: Total Population above 65 years of age, 2012-2015 (%)
Figure 53 India: Total Population above 65 years of age, 2012-2015 (%)
Figure 54 Japan: Total Population above 65 years of age, 2012-2015 (%)
Figure 55 China: Male-Female Population, 2010-2015 (%)
Figure 56 India: Male-Female Population, 2010-2015 (%)
Figure 57 Japan: Male-Female Population, 2010-2015 (%)
Figure 58 China: Varicose veins Market Revenue, 2016-2021 ($ Million)
Figure 59 India: Varicose veins Market Revenue, 2016-2021 ($ Million)
Figure 60 Japan: Varicose veins Market Revenue, 2016-2021 ($ Million)
Figure 61 Rest of APAC: Varicose veins Market Revenue, 2016-2021 ($ Million)
Figure 62 RoW: Varicose veins Market Revenue, By Product 2016-2021 ($ Million)
Figure 63 Obesity Population percentage in Middle East Countries
Figure 64 Population in UAE, By Age Group, in Thousands (2005-2030)
Figure 65 Middle East & North Africa Population, 2010-2015 ($Bn)
Figure 66 Middle East & North Africa Population, ages 65 and above (%)
Figure 67 Middle East: Varicose veins Market Revenue, 2016-2021 ($Million)
Figure 68 Africa: Varicose veins Market Revenue, 2016-2021 ($ Million)
Figure 69 Syneron Medical Ltd., Net Revenue, By Years, 2013-2016 ($Million)
Figure 70 BTG PLC., Net Revenue, By Years, 2013-2016 ($Million)
Figure 71 BTG PLC., Segment share, By 2016 (%)
Figure 72 BTG PLC., Regional share, By 2016 (%)
Figure 73 AngioDynamics, Net Revenue, By Years, 2013-2016 ($Million)
Figure 74 AngioDynamics, Net Sales, By Geography, (2016)
Figure 75 AngioDynamics, Net Sales, By Segment,(2016)
Figure 76 Medtronic, Inc. Net sales, By Years, 2013-2016 ($Billion)
Figure 77 Medtronic, Inc. Net Sales Share, By Geography, 2016 (%)
Figure 78 Medtronic, Inc. Net Sales Share, By Business segments, 2016 (%)
Figure 79 Teleflex, Net Revenue, By Years, 2013-2015 ($Billion)
Figure 80 Teleflex, Net Sales Share, By Geography, 2015
Figure 81 Teleflex, Net Sales Share, By End User, 2015 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll